??Effect of Tranexamic acid in treatment of surgical bleeding

The effect of Tranexamic acid on bleeding and hemoglobin level in patients with staghorn calculus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180209038673N1

Enrollment

120

Registered

2018-04-17

Start date

2017-01-31

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

staghorn calculus kidney. Calculus of kidney and ureter

Interventions

Intervention 1: Intervention group: Administration of 1 grTranexamic acid every 12 hours for a week(group with size more and less than 4 cm). Intervention 2: Control group: Normal Salin (group with s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with staghorn calculus candidate for percutaneous nephrolithotomy surgery

Exclusion criteria

Exclusion criteria: renal failure creatinine more than 15 consumption of vitamin E, Aspirin and warfarin

Design outcomes

Primary

Measure	Time frame
Bleeding. Timepoint: One week after the end intervention. Method of measurement: The amount of blood intake.	—

Secondary

Measure	Time frame
Hemoglobin. Timepoint: One week after the end intervention. Method of measurement: CBC analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Barzegar

Esfahan University of Medical Sciences

mehrdad.mohammadi981@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 20, 2026